Engineered immune cells take on childhood cancer in new trial
Disease control
Recruiting now
This trial tests a new treatment called hALK.CAR T cells for children and young adults with high-risk neuroblastoma that has returned or not responded to standard treatments. The therapy involves taking a patient's own immune cells, engineering them to recognize and attack cancer…
Phase: PHASE1, PHASE2 • Sponsor: Roberto Chiarle • Aim: Disease control
Last updated Jun 27, 2026 08:07 UTC